These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19527136)

  • 1. Proteomics in protein misfolding diseases.
    Stoppini M; Obici L; Lavatelli F; Giorgetti S; Marchese L; Moratti R; Bellotti V; Merlini G
    Clin Chem Lab Med; 2009; 47(6):627-35. PubMed ID: 19527136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic amyloidoses.
    Blancas-Mejía LM; Ramirez-Alvarado M
    Annu Rev Biochem; 2013; 82():745-74. PubMed ID: 23451869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic typing of amyloid deposits in systemic amyloidoses.
    Lavatelli F; Vrana JA
    Amyloid; 2011 Dec; 18(4):177-82. PubMed ID: 22080761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirming the Diagnosis of Amyloidosis.
    Wisniowski B; Wechalekar A
    Acta Haematol; 2020; 143(4):312-321. PubMed ID: 32544917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.
    Lavatelli F; Perlman DH; Spencer B; Prokaeva T; McComb ME; Théberge R; Connors LH; Bellotti V; Seldin DC; Merlini G; Skinner M; Costello CE
    Mol Cell Proteomics; 2008 Aug; 7(8):1570-83. PubMed ID: 18474516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proteomics, a new tool for an accurate typing of amyloidosis].
    Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE;
    Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pathology of Amyloidosis in Classification: A Review.
    Picken MM
    Acta Haematol; 2020; 143(4):322-334. PubMed ID: 32392555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloidosis: Insights from Proteomics.
    Dogan A
    Annu Rev Pathol; 2017 Jan; 12():277-304. PubMed ID: 27959636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New Insights into Diagnosis and Pathogenesis of Amyloidosis by Mass Spectrometric Analysis].
    Tasaki M; Obayashi K; Ando Y
    Rinsho Byori; 2016 Jun; 64(6):675-679. PubMed ID: 30695322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The workings of the amyloid diseases.
    Bellotti V; Nuvolone M; Giorgetti S; Obici L; Palladini G; Russo P; Lavatelli F; Perfetti V; Merlini G
    Ann Med; 2007; 39(3):200-7. PubMed ID: 17457717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical proteomics for diagnosis and typing of systemic amyloidoses.
    Brambilla F; Lavatelli F; Merlini G; Mauri P
    Proteomics Clin Appl; 2013 Jan; 7(1-2):136-43. PubMed ID: 23184874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue.
    Gilbertson JA; Theis JD; Vrana JA; Lachmann H; Wechalekar A; Whelan C; Hawkins PN; Dogan A; Gillmore JD
    J Clin Pathol; 2015 Apr; 68(4):314-7. PubMed ID: 25637636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical markers in early diagnosis and management of systemic amyloidoses.
    Lavatelli F; Albertini R; Di Fonzo A; Palladini G; Merlini G
    Clin Chem Lab Med; 2014 Nov; 52(11):1517-31. PubMed ID: 24870609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidoses.
    Brambilla F; Lavatelli F; Di Silvestre D; Valentini V; Palladini G; Merlini G; Mauri P
    J Proteome Res; 2013 Dec; 12(12):5642-55. PubMed ID: 24083510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Laboratory Test Using Proteomics: The Usefulness of Proteomic Techniques for Amyloid Typing].
    Tasaki M; Obayashi K; Ando Y
    Rinsho Byori; 2015 Aug; 63(8):980-5. PubMed ID: 26638436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics.
    Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of systemic AA amyloidosis in animals.
    Murakami T; Ishiguro N; Higuchi K
    Vet Pathol; 2014 Mar; 51(2):363-71. PubMed ID: 24280941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into systemic amyloidosis: the importance of diagnosis of specific type.
    Picken MM
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):196-203. PubMed ID: 17420662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics with Mass Spectrometry Imaging: Beyond Amyloid Typing.
    Lavatelli F; Merlini G
    Proteomics; 2018 Apr; 18(7):e1700353. PubMed ID: 29389069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring disappearance of monomers and generation of resistance to proteolysis during the formation of the activation domain of human procarboxypeptidase A2 (ADA2h) amyloid fibrils by matrix-assisted laser-desorption ionization-time-of-flight-MS.
    Villanueva J; Villegas V; Querol E; Avilés FX; Serrano L
    Biochem J; 2003 Sep; 374(Pt 2):489-95. PubMed ID: 12765547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.